News

In the news

Three-Way Merger Combines Focus on Physician and Patient Engagement with Industry-Leading Technology Platform to Create the Nation’s Premier, Value Based Kidney Care ProviderMarch 22, 2022
Fresenius Medical Care, a leading provider of products and services for individuals with kidney diseases, InterWell Health, a leading physician […]
New $450M Investment in Cigna Ventures to Drive Health Care Transformation, Innovation, and GrowthMarch 7, 2022
To ensure that we are positioned for this next wave of personalized, digital, and seamless health care experiences, Cigna has […]
Cigna Ventures invests in Flume HealthMarch 4, 2022
Flume Health, a New York-based health plan builder for organizations, raised $30 million in Series A funding led by Optum […]
Babyscripts Raises $7.5M in Additional Series B Funding to Roll Out Virtual Maternity Care Solution to Providers Across the U.S., Enabling Greater Access to CareNovember 30, 2021
Babyscripts, the leading virtual care platform for managing obstetrics, expects the investment to accelerate the roll out of Babyscripts Virtual […]

SEE ALL NEWS

SEE ALL PARTNERSHIP ACTIVITY

By contacting Cigna Ventures through this website, you agree and acknowledge that information you submit will not be considered or treated as confidential or proprietary unless and until a separate agreement is signed, and that Cigna Ventures and its affiliates are under no obligation to review your submission or to enter into any agreement, investment or transaction associated with the submission. In no event will Cigna Ventures or any of its affiliates be limited in, or restricted from, the pursuit of any opportunities, either alone or with third parties.

The information contained herein does not constitute a distribution, an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such distribution or offer is not authorized. In particular, the information herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States (U.S.) or for the benefit of any U.S. person (being residents of the United States. or partnerships or corporations organized under the laws of the United States), nor in any other country.

The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc.

Privacy Policy | Terms of Use | Accessibility

© 2022 Cigna. All rights reserved

This site is protected by reCAPTCHA and the Google. Privacy Policy and Terms of Service apply.